Be on the lookout for flu symptoms and know what to do if you or a family member gets sick with the flu. Learn more about flu treatments and taking care of yourself or others: http://bit.ly/2jHZSYt.
It’s this time of the year again. The flu vaccine has arrived and we are ready to vaccinate. Please consider placing an appointment with us when you are ready.
CDC’s Advisory Committee on Immunization Practices (ACIP) voted that live attenuated influenza vaccine (LAIV), also known as the “nasal spray” flu vaccine, should not be used during the 2016-2017 flu season. Therefore, we will not be administering FLUMIST this year. We apologize for the inconvenience.
3M Ultrathon Insect Repellent was developed to provide long lasting protection against mosquitoes for up to 12 hours. It repels mosquitoes, ticks, biting flies, chiggers, gnats, fleas and deer flies. It contains 34% DEET and is very easy to apply. Please contact our office for yours today.
More information of inset repellents can be found on this link below. https://www.epa.gov/insect-repellents/find-insect-repellent-right-you
Typhoid fever is a life-threatening illness caused by the bacterium Salmonella Typhi which affects 21.5 million people each year. Most cases are acquired while traveling internationally in the developing world. You can get typhoid fever if you eat food or drink beverages that have been contaminated. The infection is common in areas of the world where water is likely to be contaminated with sewage. If you are traveling to a country where typhoid is common, you should consider being vaccinated against typhoid.
It is recommended to vaccinate 1-2 weeks prior to possible exposure. The vaccine will last for approximately 3 years.
You can receive your Typhoid vaccine here at the American Clinic Tokyo. Currently, the following product is in stock: SANOFI PASTEUR’S TYPHOID VACCINE, TYPHIM VI®
WHO organizes an advisory group of experts to analyze influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System (GISRS), and issues recommendations on the composition of the influenza vaccines for the following influenza season. The following strains have been released so vaccine manufacturing will start according to these recommendations.
- A/California/7/2009 (H1N1)pdm09-like virus
- A/Hong Kong/4801/2014 (H3N2)-like virus
- B/Brisbane/60/2008-like virus
- B/Phuket/3073/2013-like virus
We expect to have vaccines available by October 2016.
Mycoplasma pneumoniae is a leading cause of respiratory infections, including “walking pneumonia.” There has been an outbreak in Tokyo and a large number of patients have been observed this season. This outbreak can continue and can also be recurrent. Common symptoms are, cough, throat pain, nasal discharge, ear pain and breathing difficulty. Diagnostic testing (rapid immunochromatographic antigen test) is not routinely performed so many patients can go unrecognized for long periods of time. Commonly used antibiotics may not be effective. Mycoplasma pneumoniae infections can be difficult to diagnose and treat, so be sure to discuss treatment strategies with your physician.